CHICAGO--Jeffrey H. Newhouse, MD, director of the division of abdominal imaging at Columbia University Medical Center in New York City, spoke with Health Imaging News about contrast-induced nephropathy (CIN), and its potential “exaggerated risk” with IV contrast injections, especially comapred with cardiac cath procedures, due to improper appropriate controls in many clinical trials that assessed its risk.
Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
